Sanghwa Kim
Gyeonggi-do, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications
Pathological characteristics and prognosis of very young patients with early breast cancer: a comparative analysis with older patients.
Journal: Acta oncologica (Stockholm, Sweden)
Published: February 17, 2026
HO-1197 as a Multifaceted Therapeutic: Targeting the Cell Cycle, Angiogenesis, Metastasis, and Tumor Immunity in Hepatocellular Carcinoma.
Journal: International journal of molecular sciences
Published: August 20, 2025
Body mass index and progesterone receptor in postmenopausal ER-positive/HER2-negative breast cancer: A nation-wide study in Korean breast cancer society and the multi-institutional cohort.
Journal: Breast (Edinburgh, Scotland)
Published: March 20, 2025
Inhibition of 11β-hydroxysteroid dehydrogenase 1 alleviates pulmonary fibrosis through inhibition of endothelial-to-mesenchymal transition and M2 macrophage polarization by upregulating heme oxygenase-1.
Journal: Cell death & disease
Published: September 27, 2024
HO-1089 and HO-1197, Novel Herbal Formulas, Have Antitumor Effects via Suppression of PLK1 (Polo-like Kinase 1) Expression in Hepatocellular Carcinoma.
Journal: Cancers
Published: December 15, 2022
Inhibition of 11β-hydroxysteroid dehydrogenase 1 relieves fibrosis through depolarizing of hepatic stellate cell in NASH.
Journal: Cell death & disease
Published: September 06, 2022
Chromenopyrimidinone exhibit antitumor effects through inhibition of CAP1 (Adenylyl cyclase-associated protein 1) expression in hepatocellular carcinoma.
Journal: Chemico-biological interactions
Published: March 29, 2022
Sorbitol dehydrogenase induction of cancer cell necroptosis and macrophage polarization in the HCC microenvironment suppresses tumor progression.
Journal: Cancer letters
Published: March 05, 2022
Efficient gene transfection to lung cancer cells via Folate-PEI-Sorbitol gene transporter.
Journal: PloS one
Published: September 23, 2021
FCH domain only 1 (FCHo1), a potential new biomarker for lung cancer.
Journal: Cancer gene therapy
Published: December 29, 2020
Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 03, 2020
Last Updated: 09/26/2026